Citius Pharmaceuticals Inc (CTXR)
3.42
+0.08
(+2.47%)
USD |
NASDAQ |
Nov 26, 10:09
Citius Pharmaceuticals Shareholders Equity (Quarterly): 85.68M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 85.68M |
March 31, 2024 | 79.37M |
December 31, 2023 | 84.73M |
September 30, 2023 | 90.83M |
June 30, 2023 | 97.70M |
March 31, 2023 | 91.21M |
December 31, 2022 | 100.43M |
September 30, 2022 | 102.83M |
June 30, 2022 | 109.74M |
March 31, 2022 | 117.60M |
December 31, 2021 | 123.96M |
September 30, 2021 | 132.18M |
June 30, 2021 | 136.68M |
March 31, 2021 | 125.16M |
December 31, 2020 | 25.20M |
September 30, 2020 | 33.67M |
June 30, 2020 | 28.74M |
March 31, 2020 | 22.44M |
December 31, 2019 | 20.38M |
September 30, 2019 | 27.15M |
June 30, 2019 | 21.51M |
March 31, 2019 | 20.87M |
December 31, 2018 | 24.18M |
September 30, 2018 | 27.87M |
June 30, 2018 | 21.64M |
Date | Value |
---|---|
March 31, 2018 | 23.50M |
December 31, 2017 | 25.86M |
September 30, 2017 | 21.95M |
June 30, 2017 | 11.59M |
March 31, 2017 | 13.99M |
December 31, 2016 | 15.16M |
September 30, 2016 | 16.77M |
June 30, 2016 | 18.16M |
March 31, 2016 | 20.43M |
December 31, 2015 | -1.590M |
September 30, 2015 | -0.6352M |
June 30, 2015 | -1.180M |
March 31, 2015 | -0.918M |
December 31, 2014 | -0.8235M |
September 30, 2014 | -0.7419M |
June 30, 2014 | -0.0314M |
March 31, 2014 | -0.0251M |
December 31, 2013 | -0.015M |
September 30, 2013 | -0.0147M |
June 30, 2013 | -0.0619M |
March 31, 2013 | -0.0575M |
December 31, 2012 | -0.0473M |
September 30, 2012 | -0.0458M |
June 30, 2012 | -0.0405M |
March 31, 2012 | -0.0336M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
20.38M
Minimum
Dec 2019
136.68M
Maximum
Jun 2021
84.66M
Average
91.21M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
Citius Oncology Inc | -- |
Merck & Co Inc | 44.50B |
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 97.09M |
Total Liabilities (Quarterly) | 10.81M |